HC Wainwright & Co. Reiterates Buy on Nuvation Bio, Maintains $17 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 91.5%

Neg 0% Neu 91.5% Pos 0%

HC Wainwright & Co. analyst Robert Burns reiterates Nuvation Bio (NYSE:NUVB) with a Buy and maintains $17 price target.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Reiterates Buy on Nuvation Bio, Maintains $17 Price Target